Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.
- Authors:
- RC Coombes, PD Badman, JP Lozano-Kuehne, X Liu, IR Macpherson, I Zubairi, RD Baird, N Rosenfeld, J Garcia-Corbacho, N Cresti, R Plummer, A Armstrong, R Allerton, D Landers, H Nicholas, L McLellan, A Lim, F Mouliere, OE Pardo, V Ferguson, MJ Seckl
- Journal:
- Nat Commun
- Citation info:
- 14(1):260
- Publication date:
- 17th Jan 2023
- Full text
- DOI